Longeveron Inc Asset Turnover Ratio (LGVN), as of third quarter 2026, current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Longeveron Inc   (NASDAQ: LGVN)
 

Longeveron Inc Asset Turnover Ratio

Quarterly Results, Trends, Rankings, Statistics

Longeveron Inc 's asset turnover ratio has remained unchanged compare to previous quarter at 0.06 in the third quarter (Sep 30 2026)

Within sector 168 more businesses have achieved higher asset turnover ratio. While ranking the asset turnover ratio, among all other companies, it is fair to say, that the company's position has deteriorated in the Third Quarter 2026 compared to the preceding quarter from 2994 to 3321.

Asset Turnover Ratio Definition


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

LGVN Asset Turnover Ratio (Sep 30 2026)
III. Quarter		 (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter
Y / Y Asset Change 52.18 % 75.38 % 1.74 % -59.85 % -47.99 %
Y / Y Revenue Change -16.06 % -9.18 % 4.46 % -39.47 % -82.28 %
Asset Turnover Ratio (TTM) 0.06 0.06 0.08 0.08 0.07
LGVN's Total Ranking # 3321 # 2994 # 2988 # 410 #
Seq. Asset Change -19.4 % 38.49 % 106.7 % -34.04 % -7.12 %
Seq. Revenue Change -59.93 % -27.89 % 9.04 % 166.42 % -56.65 %



Asset Turnover Ratio Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 169
Healthcare Sector # 493
Overall Market # 3321

Asset Turnover Ratio Statistics
High Average Low
0.11 0.06 0.04
(Dec 31 2024)   (Jun 30 2022)




LGVN Company Profile • Back to LGVN Efficiency Comparisons • Compare LGVN Asset Turnover Ratio to its Competitors



Companies with similar Asset Turnover Ratio for the quarter ending Sep 30 2026, within Healthcare Sector Asset Turnover Ratio Revenues for 12 Months ending Sep 30 2026 Assets at quarter ending Sep 30 2026
Ligand Pharmaceuticals Incorporated  0.14 $ 253.827  Millions$ 1,879.020  Millions
Bicycle Therapeutics Plc  0.13 $ 83.528  Millions$ 635.938  Millions
Kura Oncology Inc   0.12 $ 79.314  Millions$ 636.301  Millions
Voyager Therapeutics Inc   0.12 $ 25.108  Millions$ 211.603  Millions
Monte Rosa Therapeutics Inc   0.11 $ 70.325  Millions$ 643.493  Millions
Beam Therapeutics Inc   0.10 $ 146.644  Millions$ 1,404.350  Millions
Opus Genetics Inc   0.10 $ 7.914  Millions$ 76.323  Millions
Lineage Cell Therapeutics Inc   0.10 $ 10.836  Millions$ 107.112  Millions
Coya Therapeutics Inc   0.10 $ 4.689  Millions$ 47.462  Millions
Longeveron Inc   0.08 $ 1.165  Millions$ 14.743  Millions
Nexalin Technology Inc   0.08 $ 0.277  Millions$ 3.655  Millions
Crescent Biopharma Inc   0.07 $ 16.770  Millions$ 230.421  Millions
Ocular Therapeutix Inc   0.07 $ 50.384  Millions$ 704.388  Millions
Stoke Therapeutics Inc   0.07 $ 28.211  Millions$ 415.592  Millions
Intellia Therapeutics Inc   0.06 $ 52.887  Millions$ 840.157  Millions
Stablecoin Development Corporation  0.06 $ 7.246  Millions$ 126.127  Millions
Atrium Therapeutics Inc   0.06 $ 38.820  Millions$ 698.727  Millions
Seer Inc   0.05 $ 14.248  Millions$ 266.663  Millions
Nakamoto Inc   0.05 $ 30.503  Millions$ 572.769  Millions
Recursion Pharmaceuticals Inc   0.05 $ 68.232  Millions$ 1,312.008  Millions
Pluri Inc   0.05 $ 1.459  Millions$ 28.637  Millions
Abcellera Biologics Inc   0.05 $ 67.858  Millions$ 1,367.875  Millions
Lenz Therapeutics Inc   0.05 $ 12.359  Millions$ 256.189  Millions
Co diagnostics Inc   0.05 $ 0.859  Millions$ 18.906  Millions
Cytomx Therapeutics Inc   0.04 $ 14.027  Millions$ 314.207  Millions
Solana Company  0.04 $ 12.906  Millions$ 318.301  Millions
Vivos Inc  0.04 $ 0.092  Millions$ 2.349  Millions
Metagenomi Therapeutics Inc   0.04 $ 7.086  Millions$ 187.286  Millions
Aclaris Therapeutics Inc   0.03 $ 6.401  Millions$ 188.758  Millions
Ideaya Biosciences Inc   0.03 $ 36.535  Millions$ 1,166.348  Millions



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.